Should mast cells be considered therapeutic targets in multiple sclerosis? (2020)
Pinke, Karen Henriette; Zorzella-Pezavento, Sofia Fernanda Gonçalves; Lara, Vanessa Soares 
; Sartori, Alexandrina
Source: Neural Regeneration Research. Unidade: FOB
Subjects: MASTÓCITOS, ESCLEROSE MÚLTIPLA, SISTEMA NERVOSO CENTRAL, DOENÇAS DEGENERATIVAS, IMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINKE, Karen Henriette et al. Should mast cells be considered therapeutic targets in multiple sclerosis?. Neural Regeneration Research, v. No 2020, n. 11, p. 1995-2007, 2020Tradução . . Disponível em: https://doi.org/10.4103/1673-5374.282238. Acesso em: 27 nov. 2025.APA
Pinke, K. H., Zorzella-Pezavento, S. F. G., Lara, V. S., & Sartori, A. (2020). Should mast cells be considered therapeutic targets in multiple sclerosis? Neural Regeneration Research, No 2020( 11), 1995-2007. doi:10.4103/1673-5374.282238NLM
Pinke KH, Zorzella-Pezavento SFG, Lara VS, Sartori A. Should mast cells be considered therapeutic targets in multiple sclerosis? [Internet]. Neural Regeneration Research. 2020 ; No 2020( 11): 1995-2007.[citado 2025 nov. 27 ] Available from: https://doi.org/10.4103/1673-5374.282238Vancouver
Pinke KH, Zorzella-Pezavento SFG, Lara VS, Sartori A. Should mast cells be considered therapeutic targets in multiple sclerosis? [Internet]. Neural Regeneration Research. 2020 ; No 2020( 11): 1995-2007.[citado 2025 nov. 27 ] Available from: https://doi.org/10.4103/1673-5374.282238
